---
title: "Can-Fite Reports 2025 Financial Results and Ongoing Clinical Progress Highlighting Positive Data in Phase 2a Pancreatic cancer and 9 Years Cancer-Free Survival in Liver Cancer Patient | CANF Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280640690.md"
description: "Can-Fite Reports 2025 Financial Results and Ongoing Clinical Progress Highlighting Positive Data in Phase 2a Pancreatic cancer and 9 Years Cancer-Free Survival in Liver Cancer Patient | CANF Stock News"
datetime: "2026-03-26T05:31:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280640690.md)
  - [en](https://longbridge.com/en/news/280640690.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280640690.md)
---

# Can-Fite Reports 2025 Financial Results and Ongoing Clinical Progress Highlighting Positive Data in Phase 2a Pancreatic cancer and 9 Years Cancer-Free Survival in Liver Cancer Patient | CANF Stock News

Can-Fite Reports 2025 Financial Results and Ongoing Clinical Progress Highlighting Positive Data in Phase 2a Pancreatic cancer and 9 Years Cancer-Free Survival in Liver Cancer Patient | CANF Stock News

### Related Stocks

- [CANF.US](https://longbridge.com/en/quote/CANF.US.md)

## Related News & Research

- [Silexion Therapeutics Reports Positive Preliminary Immunotherapy Findings for SIL204 in KRAS-Driven Pancreatic Cancer | SLXN Stock News](https://longbridge.com/en/news/286425411.md)
- [Autonomix Medical Announces Abstract Acceptances at EuroPCR 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation | AMIX Stock News](https://longbridge.com/en/news/286772951.md)
- [Immuneering says atebimetinib-chemo trial shows 17.3-month median survival in pancreatic cancer](https://longbridge.com/en/news/287272683.md)
- [Akari reports preclinical AKTX-101 synergy with KRAS inhibitor in pancreatic cancer models](https://longbridge.com/en/news/287273431.md)
- [Propanc Biopharma’s CEO Forecasts New Medical Breakthroughs in the Fight Against Pancreatic Cancer Over the Next Decade | PPCB Stock News](https://longbridge.com/en/news/287069272.md)